Authors' response to letter to the editor regarding relationship between sodium-glucose cotransporter two inhibitors and atrial fibrillation recurrence after pulmonary vein isolation in patients with type 2 diabetes and persistent atrial fibrillation

J Cardiovasc Electrophysiol. 2024 Oct;35(10):2091-2092. doi: 10.1111/jce.16410. Epub 2024 Aug 19.

Authors

Dan Qi¹, Xiaonan Guan¹, Jianjun Zhang¹

Affiliation

¹ Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

PMID: 39161041
DOI: 10.1111/jce.16410

No abstract available

Publication types

Letter

MeSH terms

Action Potentials
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / physiopathology
Atrial Fibrillation* / surgery
Catheter Ablation / adverse effects
Diabetes Mellitus, Type 2* / diagnosis
Diabetes Mellitus, Type 2* / drug therapy
Heart Rate / drug effects
Humans
Pulmonary Veins* / physiopathology
Pulmonary Veins* / surgery
Recurrence*
Risk Factors
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Time Factors
Treatment Outcome

Substances

Sodium-Glucose Transporter 2 Inhibitors